SoylentNews is people
SoylentNews
It looks like video patent licensing agency MPEG LA is targeting the highly promising genome editing techniques of using CRISPR-Cas9. They are proposing to bundle all the relevant patents so that interested parties can rest assured they have all the necessary patents while developing their products. CRISPR-Cas9 is a set of enzymes and RNA guides that enable precise targeting of genomic regions which is quite handy in research and medicine. Note that there already is a litigation in this matter between Broad-Harvard and Berkeley.
From the press release:
"CRISPR's wide range of potential applications in medicine and agriculture, and the steadily increasing volume of intellectual property in the field, point to the need for a one-stop licensing platform to reduce litigation risk and provide efficiency, transparency and predictability to scientists and businesses worldwide," said MPEG LA President and CEO Larry Horn. "Our worldwide licensing infrastructure, trusted reputation for independence, experience, impartiality and results with patent pools, and relationships with industry and academia, including life sciences, position MPEG LA to deliver a licensing solution for the life sciences market as it did with digital video for the consumer electronics market."
(Score: 2) by takyon on Thursday December 08 2016, @03:11PM
CRISPR development is far from being finished. It can be improved in various ways. A different DNA endonuclease could be used. Photoactivatable versions [the-scientist.com] can be used. Some of these improvements could make the technique worthwhile for applications like editing human cells, by lowering the error rate to acceptable or tolerable levels. There are obviously many developments NOT out in the open, and the potential for hundreds more patents and patent disputes.
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]